IL18R1 and myeloproliferative disorder: Based on the data showing a significantly increased expression of IL-18 in myeloid and erythroid cells in patients with MPN diagnosed with advanced fibrosis, we hypothesized that IL-18 acts on stromal cell subsets expressing the IL-18 receptor 1 (IL18R1) in the bone marrow.